3-Point Analysis | Why does India have upper hand in global vaccine plan?

India is one of the largest vaccine manufacturers globally by volume and provides 70 percent of UNICEF’s requirement. Various Indian players are at the forefront of the COVID-19 vaccine development and India is also attractive for clinical trials due to the incidence of myriad diseases, cheaper healthcare services, and favourable regulations. This completes India’s bouquet of offerings for vaccine developers and manufacturers. So, does this put India in an advantageous position? Will India play a key role in global vaccination? And is India ahead of the world in efforts to end COVID-19?

Here is a 3-Point Analysis to find out how India’s vaccine manufacturing prowess places it in the fight against COVID-19.